英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Epitinib succinate |
|
2252334-12-4 |
詳細(xì)
|
CMP-5 2HCl |
|
2309409-79-6 |
詳細(xì)
|
2,6-Dibromo-4-(hydroxymethyl)phenol |
|
2316-62-3 |
詳細(xì)
|
MARK4 inhibitor 1 |
|
2271081-58-2 |
詳細(xì)
|
M2N12 |
|
2376577-06-7 |
詳細(xì)
|
IRE1α kinase-IN-1 |
|
2328097-41-0 |
詳細(xì)
|
NF-κΒ activator 1 |
|
2387524-59-4 |
詳細(xì)
|
UMB298 |
|
2266569-73-5 |
詳細(xì)
|
KB-0742 dihydrochloride |
|
2416874-75-2 |
詳細(xì)
|
AHR antagonist 5 free base |
|
2247950-42-9 |
詳細(xì)
|
ACSS2-IN-2 |
|
2332820-04-7 |
詳細(xì)
|
DDO-7263 |
|
2254004-96-9 |
詳細(xì)
|
AAPK-25 |
|
2247919-28-2 |
詳細(xì)
|
XL177A |
|
2417089-74-6 |
詳細(xì)
|
BAY 2666605 |
|
2275774-60-0 |
詳細(xì)
|
BRM/BRG1 ATP Inhibitor-2 |
|
2368900-77-8 |
詳細(xì)
|
BCL6-IN-6 |
|
2408882-54-0 |
詳細(xì)
|
(E)-1-[(E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl]-3- (3,4,5-trimethoxybenzylidene) piperidin-2-one |
|
2293951-01-4 |
詳細(xì)
|
Auristatin23 |
|
2375388-36-4 |
詳細(xì)
|
PD-1-IN-22 |
|
2349372-98-9 |
詳細(xì)
|
CRT0066854 hydrochloride |
|
2250019-91-9 |
詳細(xì)
|
DS08210767 |
|
2376334-75-5 |
詳細(xì)
|
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine |
|
237402-29-8 |
詳細(xì)
|
TRPV4 agonist-1 free base |
|
2314467-59-7 |
詳細(xì)
|
WSB1 Degrader 1 |
|
2306039-66-5 |
詳細(xì)
|
Sivopixant |
|
2414285-40-6 |
詳細(xì)
|
TH5427 |
|
2253744-56-6 |
詳細(xì)
|
AGI-43192 |
|
2377491-54-6 |
詳細(xì)
|
Tubulin inhibitor 24 |
|
2415761-65-6 |
詳細(xì)
|
P2Y2R/GPR17 antagonist 1 |
|
2395016-49-4 |
詳細(xì)
|
2-Methoxy-4-{(E)-3-oxo-3-[(E)-2-oxo-3-(3,4,5- trimethoxybenzylidene)piperidin-1-yl]prop-1-en-1-yl}phenyl acetate |
|
2293951-00-3 |
詳細(xì)
|
Compound 227105-11-5 |
|
227105-11-5 |
詳細(xì)
|
Antitumor agent-19 |
|
2379727-90-7 |
詳細(xì)
|
ms48107 |
|
2375070-79-2 |
詳細(xì)
|
LY3405105 |
|
2326428-25-3 |
詳細(xì)
|
Msr-Ratio |
|
2290635-22-0 |
詳細(xì)
|
Mito-LND |
|
2361564-49-8 |
詳細(xì)
|
HeE1-2Tyr |
|
2245195-67-7 |
詳細(xì)
|
SN-008 |
|
2249106-01-0 |
詳細(xì)
|
BOS-318 |
|
2387633-15-8 |
詳細(xì)
|
3-amino-1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one dihydrochloride |
|
2411178-94-2 |
詳細(xì)
|
DS12881479 |
|
2373065-59-7 |
詳細(xì)
|
5,6-Epoxyergosterol |
|
23637-31-2 |
詳細(xì)
|
ENFENAMIC ACID |
|
23049-93-6 |
詳細(xì)
|
K-Ras G12C-IN-4 |
|
2376328-55-9 |
詳細(xì)
|
anti-TB agent 1 |
|
2294013-78-6 |
詳細(xì)
|
Hamaline |
|
2411677-02-4 |
詳細(xì)
|
cis VH 032, amine dihydrochloride |
|
2376990-32-6 |
詳細(xì)
|
WEE1-IN-3 |
|
2272976-28-8 |
詳細(xì)
|
CVN424 |
|
2254706-21-1 |
詳細(xì)
|
HM43239 |
|
2294874-49-8 |
詳細(xì)
|
MERS-CoV-IN-1 |
|
2245697-92-9 |
詳細(xì)
|
GA-017 |
|
2351906-74-4 |
詳細(xì)
|
SU056 |
|
2376580-08-2 |
詳細(xì)
|
nerolidol acetate |
|
2306-78-7 |
詳細(xì)
|
CHMFL-PI3KD-317 |
|
2244992-76-3 |
詳細(xì)
|
Thalidomide-O-amido-C6-NH2 hydrochloride |
|
2376990-31-5 |
詳細(xì)
|
BuChE-IN-TM-10 |
|
2313524-95-5 |
詳細(xì)
|
C/EBPα inducer 1 |
|
2374285-52-4 |
詳細(xì)
|
SCR130 |
|
2377858-38-1 |
詳細(xì)
|
visamminol-3'-O- glucoside |
|
2254096-98-3 |
詳細(xì)
|
(S)-ErSO |
|
2407860-34-6 |
詳細(xì)
|
1-(2-hydroxyethyl)thymine |
|
22441-51-6 |
詳細(xì)
|
ANT3310 |
|
2410688-61-6 |
詳細(xì)
|
2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1,1-dimethylethyl)-6,7-dihydro-10-(3-methoxypropoxy)-2-oxo-, (6R)- |
|
2247932-38-1 |
詳細(xì)
|
UCM-1306 |
|
2258608-78-3 |
詳細(xì)
|
BUR1 |
|
23000-46-6 |
詳細(xì)
|
SGC-AAK1-1 |
|
2247894-32-0 |
詳細(xì)
|
Nampt-IN-5 |
|
2380013-17-0 |
詳細(xì)
|
PDE9-IN-1 |
|
2305087-92-5 |
詳細(xì)
|
Reverse transcriptase-IN-1 |
|
2380001-43-2 |
詳細(xì)
|
CDK12-IN-2 |
|
2244987-03-7 |
詳細(xì)
|
RBN-3143 |
|
2360853-16-1 |
詳細(xì)
|
SRI-37330 |
|
2322245-42-9 |
詳細(xì)
|
DC-TEADin02 |
|
2380228-45-3 |
詳細(xì)
|
(S,R,S)-AHPC-PEG2-NH2 dihydrochloride |
|
2341796-76-5 |
詳細(xì)
|
Enbezotinib |
|
2359649-81-1 |
詳細(xì)
|
SET 2 |
|
2313525-20-9 |
詳細(xì)
|
LMPTP INHIBITOR 1 hydrochloride |
|
2310135-38-5 |
詳細(xì)
|
NAcM-OPT HCl(2089293-61-6 free base) |
|
2416146-10-4 |
詳細(xì)
|
CRT0066101 dihydrochloride(956121-30-5 free base) |
|
2308510-39-4 |
詳細(xì)
|
FLT3-IN-4 |
|
2304799-09-3 |
詳細(xì)
|
AES-135 |
|
2361659-61-0 |
詳細(xì)
|
TD-165 |
|
2305936-56-3 |
詳細(xì)
|
CWHM-1552 |
|
2368253-58-9 |
詳細(xì)
|
dBRD9 HCl |
|
2341840-98-8 |
詳細(xì)
|
Thalidomide-5-NH2-CH2-COOH |
|
2412056-27-8 |
詳細(xì)
|
2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}acetic acid |
|
2377032-39-6 |
詳細(xì)
|
1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea |
|
2379727-88-3 |
詳細(xì)
|
F-1 |
|
2244775-31-1 |
詳細(xì)
|
SHIP2-IN-1 |
|
2252247-80-4 |
詳細(xì)
|
Thalidomide-O-C4-NH2 hydrochloride |
|
2376990-29-1 |
詳細(xì)
|
IMT1 |
|
2304621-31-4 |
詳細(xì)
|
HS271 |
|
2410393-15-4 |
詳細(xì)
|
PLN-1474 |
|
2408065-32-5 |
詳細(xì)
|
Proquazone |
|
22760-18-5 |
詳細(xì)
|
CHIKV-IN-2 |
|
2361289-44-1 |
詳細(xì)
|
IU1-248 |
|
2307472-03-1 |
詳細(xì)
|
Compound TPX-0046 |
|
2411115-73-4 |
詳細(xì)
|
Pumecitinib |
|
2401057-12-1 |
詳細(xì)
|